About Medibox Pharma Private Limited
Data last updated:
Medibox Pharma Private Limited is a private limited company based in Delhi, India, a subsidiary of Maxcure Nutravedics Limited. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 19 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U72900DL2016PTC399490. Its GSTIN is 29AAKCM5424F1ZC (Karnataka). The company holds 10 GST registrations, of which 9 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹38.53 Lakh. It is led by directors including Pooja Das and Manju Bist.
Its last annual general meeting (AGM) was held on 10 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 201 Mohan Place Lsc C – Block Saraswati Vihar, Delhi, India – 110034.
As per the financials filed for FY 2026, the company reported a revenue of ₹18.01 Cr, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹5.01 Cr (net margin -27.8%) and EBITDA of -₹2.34 Cr (EBITDA margin -13%).
The company has about 44 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹7 Cr and satisfied charges of ₹2 Cr on record. Court records list 7 cases involving the company, including 7 filed by the company; 7 cases are pending. The company has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹27.5 Cr; the latest was in September 2020. Its 6 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 1 smaller; the largest is Khera Pharma Private Limited with revenue of ₹22.37 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medibox.in.
Company details
CIN history
Medibox Pharma has one previous CIN (Corporate Identification Number): U72900KA2016PTC095852. The current CIN is U72900DL2016PTC399490, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72900DL2016PTC399490 | Current |
| U72900KA2016PTC095852 | Previous |
Contact details
Medibox Pharma Private Limited's registered office is in Delhi, Delhi. Its website is medibox.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Apps
- Registered Address201 Mohan Place Lsc C – Block Saraswati Vihar, Delhi, India – 110034
- IndustryE-Commerce, Online Healthcare Product Retail
To see the full contact details of Medibox Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medibox Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medibox Pharma Private Limited, buy the company report.
Financials of Medibox Pharma Private Limited
FY 2026 filings availableMedibox Pharma Private Limited reported revenue of ₹18.01 Cr (down 19% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue fell 19% in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.34 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.01 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -13% | ||||
| Net Profit Margin | -27.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medibox Pharma Private Limited, buy the company report.
Board of directors of Medibox Pharma Private Limited
Medibox Pharma has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pooja Das Also directs: Avha Lifesciences Private Limited | Director | 07 May 2026 | 0 Years 5 Months | Current |
| Manju Bist Also directs: May and Baker Pharmaceuticals Limited, Unosource Pharma Limited | Director | 06 Feb 2025 | 1 Years 8 Months | Current |
| Gopi Nath Sahu | Director | 13 Feb 2024 | 2 Years 8 Months | Current |
Peer comparison
Medibox Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Khera Pharma Private Limited | ₹22.37 Cr (FY 2024) | -1.0% | Ropar, Punjab, India | |||
| Somatico Pharmacal Private Limited | ₹22.34 Cr (FY 2025) | 0.0% | Navi Mumbai, Maharashtra, India | |||
| Shree Signify Exim Private Limited | ₹22.26 Cr (FY 2024) | -13.0% | Nagpur, Maharashtra, India | |||
| Emmar Drug Links Private Limited | ₹22.26 Cr (FY 2025) | 15.0% | Kannur, Kerala, India | |||
| Kaizen Laboratories Private Limited | ₹22.16 Cr (FY 2025) | 15.0% | Chennai, Tamil Nadu, India | |||
| Southend Pharma Pvt Ltd | ₹21.94 Cr (FY 2025) | -25.0% | Kolkata, West Bengal, India | |||
| Medibox Pharma Private Limitedthis company | ₹18.01 Cr (FY 2026) | -₹5.01 Cr | -27.8% | -19.0% | 44 | Delhi, India |
To see the full peer comparison of Medibox Pharma Private Limited, buy the company report.
Auditor
Medibox Pharma Private Limited is audited by SUBODH DUBEY & CO. for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUBODH DUBEY & CO. | FY 2021 | 024954C |
Shareholding
The shareholding of Medibox Pharma Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Medibox Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2024 | 100894203 | The Hongkong and Shanghai Banking Corporation Limited | ₹7 Cr | Open | |
| 11 Mar 2025 | 101072278 | Hdfc Bank Limited | ₹2 Cr | Satisfied |
To see the full charge records of Medibox Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Medibox Pharma Private Limited has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹27.5 Cr; the latest was in September 2020.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2020 | Secondary share transfer | Undisclosed | Buyer: Akums Drugs and Pharmaceuticals Limited , an individual Seller: 4 individuals |
| Sep 2019 | Funding round | ₹12 Cr | Investors: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: R S M Pharma Private Limited , an individual |
| Dec 2017 | Funding round | ₹12 Cr | Investors: Maxcure Nutra Vedics Limited |
| Oct 2017 | Funding round | ₹1.5 Cr | Investors: 2 individuals |
To see the full deal history of Medibox Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Medibox Pharma Private Limited has 7 court cases on record: 7 filed by Medibox Pharma. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 0 | 7 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against Rishabhnath Healthcare LLP | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Medibox Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medibox Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medibox Pharma Private Limited has a workforce of 44 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
GST
Medibox Pharma has 10 GST registrations: 9 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAKCM5424F1ZC | Karnataka | Active | 01 Jul 2017 |
| 24AAKCM5424F1CX | Gujarat | Active | 28 Apr 2019 |
| 36AAKCM5424F1CS | Telangana | Active | 01 May 2019 |
| 20AAKCM5424F1C5 | Jharkhand | Active | 15 May 2019 |
To see the full GST registrations and return filing status of Medibox Pharma Private Limited, buy the company report.
Recent activity
Medibox Pharma Private Limited has 12 board changes on record since 2016: 3 appointments and 9 cessations. The latest: Pooja Das was appointed as Director on 07 May 2026.
6 earlier events are in the company report.
Frequently asked questions
Medibox Pharma is an active private limited company based in Delhi, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 19 August 2016 (10+ years old) and is registered under CIN U72900DL2016PTC399490.
Medibox Pharma has 3 current directors:
- Pooja Das - Director
- Manju Bist - Director
- Gopi Nath Sahu - Director
The latest financial statements of Medibox Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 10 June 2026. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Medibox Pharma is 29AAKCM5424F1ZC, registered in Karnataka. The company has 10 GST registrations in all, of which 9 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAKCM5424F1CX (Gujarat), 36AAKCM5424F1CS (Telangana), 20AAKCM5424F1C5 (Jharkhand).
The CIN (Corporate Identification Number) of Medibox Pharma is U72900DL2016PTC399490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medibox Pharma has 7 court cases on record: 7 filed by the company. 7 are pending.
Medibox Pharma was incorporated on 19 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Medibox Pharma has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹27.5 Cr; the latest was in September 2020.
The peers of Medibox Pharma by revenue are Khera Pharma Private Limited, Somatico Pharmacal Private Limited, Shree Signify Exim Private Limited, Emmar Drug Links Private Limited, Kaizen Laboratories Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Pooja Das was appointed as Director on 07 May 2026. Manju Bist ceased to be Additional Director on 26 May 2025. Manju Bist was appointed as Director on 06 Feb 2025. Medibox Pharma has 12 board changes on record in total.
Medibox Pharma can be reached through the website medibox.in. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
